Advertisement
U.S. markets close in 5 hours 59 minutes
  • S&P 500

    5,139.18
    -10.24 (-0.20%)
     
  • Dow 30

    38,859.21
    +68.78 (+0.18%)
     
  • Nasdaq

    16,003.59
    -99.86 (-0.62%)
     
  • Russell 2000

    2,018.06
    -6.68 (-0.33%)
     
  • Crude Oil

    82.89
    +0.17 (+0.21%)
     
  • Gold

    2,155.50
    -8.80 (-0.41%)
     
  • Silver

    25.07
    -0.20 (-0.79%)
     
  • EUR/USD

    1.0857
    -0.0020 (-0.18%)
     
  • 10-Yr Bond

    4.3160
    -0.0240 (-0.55%)
     
  • GBP/USD

    1.2698
    -0.0031 (-0.24%)
     
  • USD/JPY

    150.6760
    +1.5780 (+1.06%)
     
  • Bitcoin USD

    63,541.82
    -3,971.87 (-5.88%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,724.65
    +2.10 (+0.03%)
     
  • Nikkei 225

    40,003.60
    +263.20 (+0.66%)
     

Martin Marietta (MLM) Declares 5% Quarterly Dividend Hike

In a bid to impress investors, Martin Marietta Materials, Inc.’s MLM board of directors approved a 5% hike in its quarterly cash dividend to 44 cents per share. The dividend will be paid on Sep 29, 2017, to shareholders of record as on Sep 5, 2017. The new figure will add up to an annual dividend of $1.76 per share.

Martin Marietta regularly returns value through share buybacks and higher dividends. The company announced a new share repurchase program in February 2015 under which it may acquire up to 20 million shares of its outstanding common stock over the next three years.

Martin Marietta has returned more than $1.1 billion to shareholders through repurchases and dividend payouts, since the inception of the program. The company’s outstanding share repurchase authorization at the end of second-quarter 2017 was $14.6 million.

Moreover, in 2016, Martin Marietta raised the quarterly cash dividend by 5% to 42 cents, which represents a cash dividend of $1.68 per share on an annualized basis. In fact, from 1994 to 2009, annual dividends saw a compound average growth rate of near 9%, reaching $1.60 peryear. Since 2009, Martin Marietta has maintained its $1.60 annual dividend despite recession, which compelled many of its peers to significantly reduce or call off dividends altogether.

Investors should keep in mind that Martin Marietta’s shares have lost 9.7% so far this year, wider than the industry’s decline of 2.2%. Earnings estimates for both the current quarter and year moved down 2.9% over the past 30 days.



We believe that the recent dividend hike will bolster investors’ confidence in the company’s financials, improve its market position against competitors and lend more upside to the stock.

Zacks Rank & Stocks to Consider

Martin Marietta carries a Zacks Rank #4 (Sell).

Better-ranked stocks in the industry include Lennar Corporation LEN, M/I Homes, Inc. MHO and KB Home KBH.

KB Home, a Zacks Rank #1 (Strong Buy) stock, is expected to witness 51.9% growth in fiscal 2017 earnings. You can see the complete list of today’s Zacks #1 Rank stocks here.

Lennar and M/I Homes carry a Zacks Rank #2 (Buy). Fiscal 2017 earnings for Lennar are expected to increase 9.5%, while full-year 2017 earnings for M/I Homes are likely to rise 37.1%.

4 Surprising Tech Stocks to Keep an Eye On

Tech stocks have been a major force behind the market’s record highs, but picking the best ones to buy can be tough. There’s a simple way to invest in the success of the entire sector. Zacks has just released a Special Report revealing one thing tech companies literally cannot function without. More importantly, it reveals 4 top stocks set to skyrocket on increasing demand for these devices. I encourage you to get the report now – before the next wave of innovations really take off.

See Stocks Now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Martin Marietta Materials, Inc. (MLM) : Free Stock Analysis Report
 
Lennar Corporation (LEN) : Free Stock Analysis Report
 
KB Home (KBH) : Free Stock Analysis Report
 
M/I Homes, Inc. (MHO) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.

Advertisement